Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC

J Thorac Oncol. 2020 Aug;15(8):e133-e136. doi: 10.1016/j.jtho.2020.03.030.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • DNA Helicases
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Nuclear Proteins
  • Transcription Factors

Substances

  • Nuclear Proteins
  • Transcription Factors
  • SMARCA4 protein, human
  • DNA Helicases